Find a Clinical Trial

Retinoblastoma Clinical Trials

Protocol Number	Title
2004CG029	COG ACNS0331: A Study Evaluating Limited Target Volumne Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
2005LS023	MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors
2006CG023	COG ARET0332: A Study of Unilaterial Retinoblastoma with and without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
2006CG033	COG ADVL0413: A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias
2007CG010	COG ADVL0612: A Phase I Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors
2007IS117	Amgen 20050252: A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors
2008CG069	COG ADVL0714 "A Phase I Study of VEGF Trap (NSC# 724770, IND #100137) in Children with Refractory Solid Tumors"
2009CG014	COG ADVL0821 A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, IND# 100947, NSC# 742460) in Children With Relapsed/Refractory Solid Tumors

8 trials displayed